Please provide your email address to receive an email when new articles are posted on . Compared with a dual therapy inhaler, a triple therapy inhaler improved inspiratory capacity in those with COPD.
Please provide your email address to receive an email when new articles are posted on . A variety of options/tools are needed when treating patients with severe emphysema and breathlessness. A phase 3 ...
Registry analysis suggests endoscopic lung volume reduction yields similar physiologic gains across sexes, but women report ...
Credit: Getty Images. The 2024 GOLD COPD Report includes updated research and recommendations that reflect shifts in thinking on COPD management. Vogelmeier, who heads the Department of Medicine, ...
One patient could only walk 15 to 20 steps before needing to get back on her oxygen, making it difficult to find motivation to engage in daily activities. Another patient struggled with severe ...
NEW YORK (Reuters Health) - Treatment with a stent coated with the drug paclitaxel to reduce hyperinflation of the lungs appears to be a feasible treatment for patients with severe emphysema, ...
Scientists recently discovered differences in how long-term consumption of cannabis and tobacco affect the lungs. A study published in the American Journal of Respiratory and Critical Care Medicine ...
The current flu season has been challenging for patients and healthcare providers in a variety of ways. According to the Centers for Disease Control and Prevention (CDC), seasonal influenza activity ...
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive treatments for severe lung disease, today announced the publication of long ...
Mountain View, CA, October 9, 2007 - Broncus Technologies, Inc., a medical device company investigating the airway bypass procedure for the treatment of emphysema, today announced that the results of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results